Skip to main content

Clinical Trials Search at Vanderbilt-Ingram Cancer Center



Pembrolizumab in Treating Patients with Triple-Negative Breast Cancer

Breast

This randomized phase III trial studies how well pembrolizumab works in treating patients with triple-negative breast cancer. Monoclonal antibodies, such as pembrolizumab, may interfere with the ability of tumor cells to grow and spread.
Breast
III
Rexer, Brent
NCT02954874
ECOGBRES1418

To learn more about any of our clinical
trials, call 1-800-811-8480 or complete
the online Self-Referral Form here: